Cheson, Bruce D. http://orcid.org/0000-0002-6246-4308
Nowakowski, Grzegorz http://orcid.org/0000-0002-6955-9393
Salles, Gilles
Article History
Received: 30 December 2020
Revised: 23 February 2021
Accepted: 3 March 2021
First Online: 5 April 2021
Conflict of interest
: B.D.C.—Advisory boards/consulting—Morphosys, Karyopharm, BMS/Celgene, Kite, Epizyme, Beigene, Symbio, TG Therapeutics; G.N.—Celgene/BMS, Morphosys, Curis, Seattle Genetics, Kymera, Kite, Ryvu; G.S.—Morphosys, Abbvie, Autolus, Beigene, BMS/Celgene, Genmab, Roche, Janssen, Debiopharm, Milteniy, Novartis, Velosbio.